Marozid

Losartan potassium, the active ingredient in Marozid, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It is combined with hydrochlorothiazide, a thiazide diuretic, to treat elevated blood pressure in adult patients.

GNH USA supplies Marozid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marozid is an antihypertensive medication that acts on the renin‑angiotensin‑aldosterone system and renal sodium handling. - Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Renal hypertension: improves blood pressure control in patients with kidney‑related hypertension. - Hypertension with fluid retention: combines vasodilation and diuresis to manage blood pressure and excess fluid.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urination - Electrolyte disturbances (e.g., low potassium) - Mild gastrointestinal upset

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Acute kidney injury or worsening renal function - Hyperkalemia - Angioedema or severe allergic reaction - Hepatic dysfunction - Significant drops in blood pressure (hypotension).

Patients should be monitored for safety and appropriate use. - Blood pressure monitoring: ensure target levels are achieved without excessive drop. - Renal function assessment: check serum creatinine and eGFR before and during therapy. - Electrolyte surveillance: monitor sodium, potassium, and uric acid levels regularly. - Caution in diabetes: watch for changes in blood glucose control. - Avoid in severe liver disease: impaired metabolism may increase risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Drug interactions can affect efficacy or increase toxicity.

Major Interactions (Avoid): - Aliskiren (especially in diabetic patients): may cause excessive potassium rise. - Potassium‑containing supplements or salt substitutes: risk of hyperkalemia. - Lithium: increased lithium levels and toxicity. - NSAIDs (e.g., ibuprofen, naproxen): may blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors or other ARBs: additive blood pressure lowering, monitor for hypotension. - Other diuretics: may cause excessive diuresis or electrolyte loss. - CYP450 inhibitors (e.g., fluconazole): can increase losartan levels. - Antidiabetic agents: monitor glucose as blood pressure changes may affect glycemic control.